Russian Scientists Discover Way to Increase Effectiveness of COVID-19 Vaccines
Moscow - Saba:
Scientists from the Institute of Bioorganic Chemistry of the Russian Academy of Sciences, in collaboration with the Research Institute of Systems Biology and Medicine, have discovered a way to improve COVID-19 vaccines by enhancing the body's immune response.
The researchers focused their study on the S protein receptors of five coronavirus strains, including the Wuhan-Hu-1, Alpha, Delta, Gamma, and Omicron strains. The results of the study showed that the S protein in the Omicron strain degrades differently than in other strains, affecting the immune response.
Anna Kudyryaeva, the project supervisor, explained that this discovery helps understand the mechanisms of interaction between the virus and the immune system and provides guidance for the development of a new generation of vaccines that enhance the effectiveness of the immune response and provide better protection against new coronavirus variants.
Whatsapp Telegram Email Print
more of (International)
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Saba Yemen
5 days ago
- Saba Yemen
Russian Scientists Develop Coating to Protect Aircraft Engines
Moscow - (Saba): Scientists from the Ural Federal University and the Institute of Electrophysics of the Ural Branch of the Russian Academy of Sciences have developed an innovative coating made of silicon, aluminum, carbon, and nitrogen that can protect aircraft engine components from oxidation at extreme temperatures. The development combines low synthesis temperatures of up to 400°C, a high deposition rate, and high hardness. All of this will reduce the cost of manufacturing parts and extend the life of civil aircraft and helicopter engines, according to the Scientific Russia portal. The study, supported by the Russian Science Foundation and published in the journal "Ceramics," features high oxidation resistance at high temperatures. This means that in an oxygen-containing environment, when heated, a barrier layer is formed due to the aluminum content, preventing oxygen from penetrating deep into the protected material. The difficulty of obtaining such multicomponent functional coatings is due to the need to create a dense structure with the required chemical elements, according to Andrey Menshakov, a senior researcher at the Laboratory of Photovoltaic Materials at the Ural Federal University and the Institute of Electrophysics of the Ural Branch of the Russian Academy of Sciences. The coating was obtained using a hybrid technology combining aluminum evaporation and plasma activation of organosilicon. Experiments have shown that the new material has a hardness of up to 31 gigapascals (comparable to diamond-like coatings) and a dense, defect-free structure. By comparison, conventional methods for creating such protective films on the surface of turbine elements require temperatures above 1,000 degrees Celsius and often lead to the formation of various defects. Over two years, the scientists conducted more than ten series of tests, resulting in the creation of several hundred samples. According to the researchers, choosing the optimal conditions made it possible to achieve the formation of a dense nanostructured coating with the desired chemical composition, ensuring the new composite's high mechanical properties. Andrey Menshakov added, "We were able to vary the compounding conditions over a wide range, and the process itself is carried out at relatively low temperatures (100, 200, 400 degrees Celsius). This allows the application of protective coatings not only to steel and titanium products, but also to low-melting materials such as polycarbonate." We also face no obvious restrictions on scaling the facility for industrial production; in this case, everything depends directly on the task at hand. Plans include testing the coating on real components of gas turbines and jet engines, as well as adapting the technology for other industries. Whatsapp Telegram Email Print more of (International)
Saba Yemen
26-05-2025
- Saba Yemen
Study: Reveals How Viral Infection Turns Your Joints into Source of Chronic Pain
Washington - (Saba): A recent scientific study has revealed that the mysterious mechanism by which the chikungunya virus causes chronic joint pain closely resembles autoimmune diseases, such as rheumatoid arthritis. Although most cases resolve spontaneously within one to two weeks, approximately 30-40% of patients may suffer from chronic joint pain that lasts for months or even years, with some potentially developing rheumatoid-like arthritis. Chikungunya virus is the virus that causes chikungunya disease (CHIKV), an acute infection transmitted to humans through the bites of Aedes aegypti and Aedes albopictus mosquitoes, the two species responsible for transmitting dengue fever. The disease is characterized by the sudden onset of symptoms, including a high fever and severe joint pain, particularly in the extremities, accompanied by a rash, muscle pain, and headache. The results of a new study, published in the journal Cell Reports Medicine, pave the way for a deeper understanding of the complex relationship between this viral infection and autoimmune diseases. The study, conducted by a team from the La Jolla Institute for Immunology, analyzed blood samples from patients exposed to chikungunya in Colombia. The researchers tracked the behavior of immune cells, particularly CD4+ helper T cells, in combating the virus. What surprised the research team was the discovery that these cells—and not CD8+ killer T cells, as expected—led the fight against the virus and persisted in the body for years after the infection cleared. The data show that 87% of patients retained these cells in their blood six years after the initial infection, while killer cells were detected in only 13% of cases. Even more striking is that these helper cells switch to a "monofunctional" pattern, essentially secreting the inflammatory molecule TNF-alpha continuously, even after the virus has been eliminated. This abnormal behavior of immune cells closely resembles what we see in autoimmune diseases, where the immune system attacks healthy body tissue. "We would normally expect to see this pattern of immune response in autoimmune diseases such as rheumatoid arthritis, not in viral infections," says Dr. Daniela Weisskopf, lead researcher of the study. This discovery provides a compelling scientific explanation for why many patients suffer from chronic joint pain that can persist for years after contracting the virus. These findings are particularly important in light of the widespread spread of the virus in more than 110 countries, and the similarity of its symptoms to other conditions such as "long COVID" and the long-term effects of dengue fever. They also open the door to developing more precise treatments that target these specific inflammatory pathways, and perhaps the use of TNF-alpha inhibitors, which have proven effective in some autoimmune diseases. Whatsapp Telegram Email Print more of (International)
Saba Yemen
19-05-2025
- Saba Yemen
WHO: We face $1.7 billion deficit over next two years
Geneva - Saba: Director-General of the World Health Organization Tedros Adhanom Ghebreyesus revealed in Geneva on Monday that the organization faces a $1.7 billion deficit over the next two years. Tedros said this figure is not enough and may be equivalent to what is spent on military equipment worldwide every eight hours. He stated that the WHO has reduced its senior management body from 14 to seven positions and the number of departments from 76 to 34. Among those leaving is Mike Ryan, the Emergency Response Coordinator, who became famous during the COVID-19 pandemic for his public press conferences. The number of staff worldwide will also be reduced by 20%, from approximately 9,500. The WHO's financial crisis surfaced with the withdrawal of the United States and Argentina from the UN organization, which was founded in 1948. The United States contributed approximately one-fifth of the WHO's expenditures. Tedros' remarks came on the first day of the WHO's eight-day annual assembly in Geneva. The meeting will focus primarily on the formal adoption of a long-awaited international treaty on global pandemics. The agreement, developed at record speed in response to lessons learned from the COVID-19 pandemic, aims to prevent the chaos seen in the global scramble for medical supplies and ensure more equitable vaccine distribution in future health crises. The treaty is scheduled to be formally adopted on Tuesday. Whatsapp Telegram Email Print
